Opiant Pharmaceuticals, Inc. announced that members of the company’s senior management team will participate in the following virtual investor conferences
SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today announced that members of the company’s senior management team will participate in the following virtual investor conferences:
- H.C. Wainwright 23rd Annual Global Investment Conference
September 13-15, 2021
On-demand presentation will be available at 7:00am ET on September 13; hosting 1-on-1 meetings - Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 20-23, 2021
Presentation on September 20 at 4:35 pm ET; hosting 1-on-1 meetings
- Cantor 2021 Virtual Global Healthcare Conference
September 27-30, 2021
Fireside chat on September 29 at 4:00 pm ET; hosting 1-on-1 meetings
A webcast of each presentation and fireside chat will be accessible on the Opiant website.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
